Valuation: G MEDPAR

Market Cap 723K 620K 580K 530K 1M 69.23M 1.01M 6.86M 2.67M 34.76M 2.71M 2.66M 115M P/E 2021
-1.29x
P/E 2022 -0.17x
Enterprise Value 2.52M 2.16M 2.02M 1.85M 3.49M 241M 3.52M 23.91M 9.3M 121M 9.46M 9.26M 401M EV / Sales 2021
4.92x
EV / Sales 2022 1.15x
Free-Float
-
Yield 2021 *
-
Yield 2022 -
1 week 0
Extreme 0.0001
0
1 month 0
Extreme 0.0001
0
Current year 0
Extreme 1.0E-6
0
1 year 0
Extreme 1.0E-6
0.03
3 years 0
Extreme 1.0E-6
0.1
5 years 0
Extreme 1.0E-6
235.9
10 years 0
Extreme 1.0E-6
235.9
Manager TitleAgeSince
Chief Executive Officer 75 02/10/2014
Director of Finance/CFO 46 30/07/2022
Chief Tech/Sci/R&D Officer 56 30/11/2017
Director TitleAgeSince
Director/Board Member 75 02/10/2014
Chairman 72 20/08/2014
Director/Board Member 76 23/02/2017
Date Insider Type Main position Quantity % Market Cap.
31/03/23
AWM Investment Co., Inc.
SellCompany 737,500 37.5554%
31/03/23
AWM Investment Co., Inc.
OtherCompany 1,437,500 73.2011%

Financials

2021 2022
Net sales 5.06M 4.33M 4.06M 3.71M 7M 484M 7.07M 47.98M 18.66M 243M 18.99M 18.58M 805M 4.42M 3.79M 3.54M 3.24M 6.11M 423M 6.18M 41.93M 16.3M 213M 16.6M 16.24M 703M
Net income -14.76M -12.65M -11.83M -10.82M -20.41M -1.41B -20.63M -140M -54.44M -710M -55.41M -54.21M -2.35B -13.52M -11.59M -10.84M -9.91M -18.7M -1.29B -18.9M -128M -49.88M -650M -50.77M -49.67M -2.15B
Net Debt 2.41M 2.06M 1.93M 1.77M 3.33M 231M 3.37M 22.84M 8.88M 116M 9.04M 8.85M 383M 1.8M 1.54M 1.44M 1.32M 2.49M 172M 2.51M 17.05M 6.63M 86.4M 6.75M 6.6M 286M
Logo G MEDPAR
G Medical Innovations Holdings Ltd. is a mobile health (mHealth) and e-health company. The Company is focused on the development of mHealth and telemedicine solutions and monitoring service platforms. It develops and markets clinical and consumer medical-grade health monitoring solutions and offers end-to-end support for e-health projects. Its product lines consist of its Prizma medical device, a clinical grade device that can transform any smartphone into a medical monitoring device enabling both healthcare providers and individuals to monitor, manage and share a wide range of vital signs and biometric indicators and Extended Holter Patch System, a multi-channel patient-worn biosensor that captures electrocardiography data continuously, including its QT Prolongation Syndrome Detection Capabilities Patch. Its monitoring services include the provision of independent diagnostic testing facilities and private monitoring services. It also develops wireless vital signs monitoring systems.
Employees
-
Sector
-
Date Price Change Volume
24/08/26 US$0.000100 0.00% 1,322
  1. Stock Market
  2. Stocks
  3. GMVDF Stock